An error occurred retrieving publication content to display, please try again.
Home >> Journals >> Health Technology Assessment >> Page Not FoundPlease choose a page from the navigation or try a website search above to find the information you need.
Determining the long term effectiveness and costs of regenerative medicines will be associated with considerable uncertainty and bias, but existing methods are sufficient to incorporate this uncertainty for decision making.
{{author}}{{author}}{{($index > metadata.AuthorsAndEtalArray.length-1) ? ',' : '.'}}
Robert Hettle, Mark Corbett, Sebastian Hinde, Robert Hodgson, Julie Jones-Diette, Nerys Woolacott & Stephen Palmer.
Robert Hettle 1, Mark Corbett 2, Sebastian Hinde 1, Robert Hodgson 2, Julie Jones-Diette 2, Nerys Woolacott 2, Stephen Palmer 1,*
1 Centre for Health Economics, University of York, York, UK
2 Centre for Reviews and Dissemination, University of York, York, UK
* Corresponding author Email: stephen.palmer@york.ac.uk
Funding: {{metadata.Funding}}
{{metadata.Journal}} Volume: {{metadata.Volume}}, Issue: {{metadata.Issue}}, Published in {{metadata.PublicationDate | date:'MMMM yyyy'}}
https://doi.org/{{metadata.DOI}}
Citation:{{author}}{{ (($index < metadata.AuthorsArray.length-1) && ($index <=6)) ? ', ' : '' }}{{(metadata.AuthorsArray.length <= 6) ? '.' : '' }} {{(metadata.AuthorsArray.length > 6) ? 'et al. ' : ''}}. {{metadata.JournalShortName}} {{metadata.PublicationDate | date:'yyyy'}};{{metadata.Volume}}({{metadata.Issue}})
[Image - Crossmark status check]The full text of this issue is available as a PDF document from the Toolkit section on this page.
The full text of this issue is available as a PDF document from the Toolkit section on this page.
No responses have been published.
An error has occurred in processing the XML document
© NIHR 2024